These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23307830)

  • 1. The association between self-reported lifestyle changes and health-related quality of life in coronary patients: the EUROASPIRE III survey.
    De Smedt D; Clays E; Annemans L; Boudrez H; De Sutter J; Doyle F; Jennings C; Kotseva K; Pająk A; Pardaens S; Prugger C; Wood D; De Bacquer D
    Eur J Prev Cardiol; 2014 Jul; 21(7):796-805. PubMed ID: 23307830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey.
    De Smedt D; Clays E; Annemans L; Doyle F; Kotseva K; Pająk A; Prugger C; Jennings C; Wood D; De Bacquer D
    Int J Cardiol; 2013 Sep; 168(2):898-903. PubMed ID: 23201081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
    Kotseva K; Wood D; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Amouyel P; Bruthans J; Castro Conde A; Cífková R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pajak A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D;
    Eur J Prev Cardiol; 2016 Apr; 23(6):636-48. PubMed ID: 25687109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Lancet; 2009 Mar; 373(9667):929-40. PubMed ID: 19286092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.
    Kotseva K; De Bacquer D; Jennings C; Gyberg V; De Backer G; Rydén L; Amouyel P; Bruthans J; Cifkova R; Deckers JW; De Sutter J; Fraz Z; Graham I; Keber I; Lehto S; Moore D; Pajak A; Wood D;
    Glob Heart; 2017 Dec; 12(4):315-322.e3. PubMed ID: 26994643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse lifestyle and health-related quality of life: gender differences in patients with and without chronic conditions.
    Põlluste K; Aart A; Kallikorm R; Kull M; Kärberg K; Müller R; Ots-Rosenberg M; Tolk A; Uhlinova J; Lember M
    Scand J Public Health; 2016 Mar; 44(2):209-16. PubMed ID: 26553249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EUROASPIRE-IV: European Society of Cardiology study of lifestyle, risk factors, and treatment approaches in patients with coronary artery disease: Data from Turkey].
    Tokgözoğlu L; Kayıkçıoğlu M; Altay S; Aydoğdu S; Barçın C; Bostan C; Çakmak HA; Çatakoğlu AB; Emet S; Ergene O; Kalkan AK; Kaya B; Tulunay Kaya C; Kaymaz C; Koylan N; Kültürsay H; Oğuz A; Özpelit E; Ünlü S
    Turk Kardiyol Dern Ars; 2017 Mar; 45(2):134-144. PubMed ID: 28424435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Readiness for smoking cessation in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey.
    Prugger C; Wellmann J; Heidrich J; De Bacquer D; De Backer G; Périer MC; Empana JP; Reiner Ž; Fras Z; Jennings C; Kotseva K; Wood D; Keil U;
    Eur J Prev Cardiol; 2015 Sep; 22(9):1212-9. PubMed ID: 25516535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking behaviour in European patients with established coronary heart disease.
    Scholte op Reimer W; de Swart E; De Bacquer D; Pyörälä K; Keil U; Heidrich J; Deckers JW; Kotseva K; Wood D; Boersma E
    Eur Heart J; 2006 Jan; 27(1):35-41. PubMed ID: 16210309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EQ-5D versus SF-12 in coronary patients: are they interchangeable?
    De Smedt D; Clays E; Annemans L; De Bacquer D
    Value Health; 2014; 17(1):84-9. PubMed ID: 24438721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among medication adherence, lifestyle modification, and health-related quality of life in patients with acute myocardial infarction: a cross-sectional study.
    Lee YM; Kim RB; Lee HJ; Kim K; Shin MH; Park HK; Ahn SK; Kim SY; Lee YH; Kim BG; Lee H; Lee WK; Lee KS; Kim MJ; Park KS
    Health Qual Life Outcomes; 2018 May; 16(1):100. PubMed ID: 29788961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EUROASPIRE III: a comparison between Turkey and Europe].
    Tokgözoğlu L; Kaya EB; Erol C; Ergene O;
    Turk Kardiyol Dern Ars; 2010 Apr; 38(3):164-72. PubMed ID: 20675993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifestyle behaviour and risk factor control in coronary patients: Belgian results from the cross-sectional EUROASPIRE surveys.
    De Smedt D; De Sutter J; De Pauw M; Vandekerckhove H; Trouerbach J; De Backer G; Willems AM; Pardaens S; Vervaet P; Deweerdt N; De Bacquer D
    Acta Cardiol; 2019 Feb; 74(1):21-27. PubMed ID: 29458303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II.
    Blanchard CM; Courneya KS; Stein K;
    J Clin Oncol; 2008 May; 26(13):2198-204. PubMed ID: 18445845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking prevalence in coronary patients from EuroAspire III Romania.
    Crăciun L; Avram A; Iurciuc S; Sarău C; Avram C; Căprariu M; Gojka G; Gaiţă D; Mancaş S
    Pneumologia; 2009; 58(3):190-4. PubMed ID: 19817318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology.
    Snaterse M; Deckers JW; Lenzen MJ; Jorstad HT; De Bacquer D; Peters RJG; Jennings C; Kotseva K; Scholte Op Reimer WJM;
    Int J Cardiol; 2018 May; 258():1-6. PubMed ID: 29544918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey.
    van Berkel TF; Boersma H; De Baquer D; Deckers JW; Wood D
    Eur Heart J; 1999 Nov; 20(22):1630-7. PubMed ID: 10543926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey.
    Kotseva K; Wood D; De Backer G; De Bacquer D;
    Eur J Prev Cardiol; 2013 Oct; 20(5):817-26. PubMed ID: 22718794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.